The Global Amniotic Membrane Market to reach USD 2.9 Billion in 2026
The global amniotic membrane market size is valued at USD about 1 billion in 2019 and is estimated to grow with healthy growth rate of more than 12.6% during the forecast period. Amniotic membrane is a mixture of tissues and cells that assists in wound healing by serving as a base for soft tissue re-growth. These are most used as a biological bandage for repairing or removing damaged eye tissue in the eye surgery. The rising aging population, the increase in amniotic membrane-based transplants globally, and increasing understanding of disease are driving the growth of the global market for amniotic membranes. According to the National institute of health (NIH), United States, global geriatric population is expected to reach to about 1.6 billion by the end of 2050 from 617 million in 2015. However, increasing healthcare cost is projected to restrain market growth.
The regional analysis of global Amniotic Membrane Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading/significant region across the world in terms of market share owing to Increasing prevalence of cicatricial pemphigoid and Stevens-Johnson syndrome; pterygium; persistent epithelial defects with ulceration; conjunctival surface reconstruction; and ocular surface reconstruction in European patients with chemical and thermal burns are driving growth in the amniotic membrane market in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as rising number of surgeries, increasing number of reconstruction procedures and cosmetic surgeries would create lucrative growth prospects for the Residential Energy Management market across Asia-Pacific region.
Major market player included in this report are:
Applied Biologics
Alliqua BioMedical, Inc.
Integra LifeSciences
Skye Biologics Inc.
Amniox Medical, Inc.
Katena Products, Inc.
Human Regenerative Technologies, LLC
Amnio Technology, LLC
Osiris Therapeutics, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type
Cryopreserved Amniotic Membrane
Lyophilized Amniotic Membrane
By Application
Surgical Wounds
Stem Cell Biology
Regenerative Medicine
Prenatal Diagnosis
By End User
Hospitals and Clinics
Ambulatory Surgical Centers
Research Centers and Laboratory
By Region:
North America
Asia Pacific
Latin America
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026

Target Audience of the Global Residential Energy Management Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers